세계의 엑소좀 연구 시장(-2028년) : 제품 및 서비스(키트, 시약(항체, 분리정제, 기기), 적응증(암, 감염증), 용도(바이오마커, 백신), 제조 서비스(줄기세포)별

Exosome Research Market by Product & Service (Kits, Reagents (Antibodies, Isolation Purification), Instruments), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell) - Global Forecast to 2028

US $ 4,950 ￦ 6,967,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650 ￦ 9,359,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150 ￦ 11,471,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000 ￦ 14,075,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

보고서 개요

조사 범위
조사 대상년도	2021-2028년
기준년도	2022년
예측 기간	2023-2028년
단위	금액(USD)
부문	제품&서비스, 적응증, 용도, 제조 서비스, 최종 사용자
대상 지역	북미, 유럽, 아시아태평양 및 기타 지역

엑소좀 연구 시장 규모는 2023년 약 1억 6,900만 달러에서 예측 기간 동안 16.0%의 연평균 복합 성장률(CAGR)을 나타내고, 2028년에는 3억 5,600만 달러 규모까지 성장할 것으로 예상됩니다.

암, 신경퇴행성 질환, 심혈관 질환과 같은 만성질환의 발병률이 증가하면서 고급 진단 및 치료 솔루션에 대한 수요가 증가함에 따라 시장 성장에 영향을 미치고 있습니다. 엑소좀은 바이오마커 및 치료 전달체로서의 잠재력을 가지고 있어 이러한 수요에 대응할 수 있는 위치에 있습니다.

제품 및 서비스별로는 키트 및 시약 부문이 2022년 가장 큰 점유율을 차지할 것으로 예상됩니다. 키트 및 시약은 연구자들에게 즉시 사용 가능한 솔루션을 제공하고 엑소좀 연구와 관련된 복잡한 프로세스를 단순화하기 때문에 성장을 주도하고 있습니다. 이러한 키트의 편의성과 사용자 친화적인 특성은 특히 엑소좀 분리 및 분석에 대한 광범위한 전문 지식이 없는 연구자들 사이에서 널리 보급되고 있습니다.

지역별로는 북미가 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 미국 국립보건원(NIH)과 같은 정부 기관은 생물 의학 연구에 많은 자금을 할당하고 있습니다. 이 자금은 엑소좀 연구와 관련된 다양한 프로젝트를 지원하고 있습니다. 정부 지원은 연구자와 연구 기관에 중요한 재정적 지원을 제공하고 이 분야의 혁신과 발전을 촉진합니다. 이러한 요인들은 북미 엑소좀 연구 시장의 성장에 기여하고 있습니다.

세계 엑소좀(Exosome) 연구 시장을 조사했으며, 시장 개요, 시장 영향요인 분석, 기술 및 특허 동향, 규제 환경, 시장 규모 추이 및 예측, 각 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• 고객의 비즈니스에 영향을 미치는 동향/파괴적 변화
• 가격 분석
• 밸류체인 분석
• 공급망 분석
• 에코시스템/시장 맵
• 기술 분석
• 특허 분석
• 주요 컨퍼런스 및 이벤트
• 규제 분석
• Porter의 Five Forces 분석
• 주요 이해관계자와 구입 기준

제6장 엑소좀 연구 시장 : 제품 및 서비스별

• 키트 및 시약
  • 항체
  • 분리, 정제, 정량 키트 및 시약
  • 기타
• 기기
• 서비스

제7장 엑소좀 연구 시장 : 적응증별

• 암
  • 폐암
  • 유방암
  • 전립선암
  • 결장직장암
  • 기타
• 신경 퇴행성 질환
• 심혈관 질환
• 감염증
• 기타

제8장 엑소좀 연구 시장 : 용도별

• 바이오마커
• 백신 개발
• 조직 재생
• 기타

제9장 엑소좀 연구 시장 : 최종사용자별

• 학술연구기관
• 제약 및 바이오테크놀러지 기업
• 병원 및 임상 검사 기관

제10장 엑소좀 연구 시장 : 제조 서비스별

• 줄기세포 유래 엑소좀 제조
• 수지상세포 유래 엑소좀 제조
• 기타

제11장 엑소좀 연구 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 기타 지역

제12장 경쟁 구도

• 개요
• 주요 기업의 전략
• 매출 분석
• 시장 점유율 분석
• 기업 평가 매트릭스
• 신규 기업/중소기업 평가 매트릭스
• 경쟁 시나리오

제13장 기업 개요

• 주요 기업
  • THERMO FISHER SCIENTIFIC INC.
  • QIAGEN
  • LONZA
  • SYSTEM BIOSCIENCES, LLC
  • BIO-TECHNE
  • DANAHER CORPORATION
  • AMSBIO
  • ROOSTERBIO, INC.
  • MILTENYI BIOTEC
  • NORGEN BIOTEK CORP.
• 기타 기업
  • AETHLON MEDICAL, INC.
  • ANJARIUM BIOSCIENCES AG
  • CILOA
  • INNOVAPREP, LLC
  • CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC,
  • ILIAS BIOLOGICS INC.
  • UNCHAINED LABS
  • RION INC.
  • CELL GUIDANCE SYSTEMS LLC
  • INOVIQ
  • NX PHARMAGEN
  • EXOPHARM
  • EVERZOM
  • NANOSOMIX
  • CREATIVE BIOLABS

제14장 부록

LSH

영문 목차

영문목차

Report Description

Scope of the Report
Years Considered for the Study	2021-2028
Base Year	2022
Forecast Period	2023-2028
Units Considered	Value (USD) Million
Segments	Product & Service, Indication, Application, Manufacturing Service, and End User
Regions covered	North America, Europe, Asia Pacific, Rest of World

The exosome research market is projected to reach USD 356 million by 2028 from an estimated USD 169 million in 2023, at a CAGR of 16.0% during the forecast period. The growth of this market can be attributed to the increasing incidence of chronic diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions, which has driven the demand for advanced diagnostic and therapeutic solutions. Exosomes, with their potential as biomarkers and therapeutic delivery vehicles, are positioned to address this demand.

"The kits & reagents segment accounted for the largest share by product & services in 2022."

In 2022, the platform segment accounted for the largest share of product & service in the global exosome research market. The factors like kits and reagents provide researchers with ready-to-use solutions, simplifying the complex processes involved in exosome research is impending growth of the segment. The convenience and user-friendly nature of these kits contribute to their widespread adoption, especially among researchers who may not have extensive expertise in exosome isolation and analysis.

"The North America region continued to dominate the exosome research market during the forecast period of 2023-2028."

North America dominated the global exosome research market in 2022. Government agencies in North America, such as the National Institutes of Health (NIH) in the United States, allocate significant funding to biomedical research. This funding supports a wide range of projects, including those related to exosome research. Government support provides a critical financial boost to researchers and institutions, fostering innovation and advancement in the field. These factors are contributing to the growth of the North American exosome research market.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific, Inc. (US)
• Bio-Techne (US)
• System Biosciences, LLC (US)
• QIAGEN (Germany)
• Lonza (Switzerland)
• NX Pharmagen (US)
• NanoSomiX (US)
• Miltenyi Biotech (Germany)
• Norgen Biotek Corp. (Canada)
• AMSBio (UK)
• Aethlon Medical, Inc. (US)
• Anjarium Biosciences AG (UK)
• Ciloa (France)
• InnovaPrep LLC (US)
• Creative Medical Technologies Holdings, Inc. (US)
• ILIAS Biologics, Inc. (South Korea)
• Unchained Labs (US)
• Rion, Inc. (US)
• Cell Guidance System, LLC (UK)
• INOVIQ (Australia)
• Danaher Corporation (US)
• Exopharm (Australia)
• Everzom (France)
• RoosterBio, Inc. (US)
• Creative Biolabs (US)

Research Coverage:

This research report categorizes the exosome research market by product & service (reagents & kits (antibodies, isolation purification, quantitation kits & reagents, and other kits & reagents) instruments, service), by indication (cancer indication (lung cancer, breast cancer, prostate cancer, colorectal cancer, other cancers), neurodegenerative diseases, cardiovascular diseases, infectious diseases, and other indications), by application (biomarkers, vaccine development, tissue regeneration, and other applications), by manufacturing services (stem cell-derived exosome manufacturing services, dendritic cell-derived exosome manufacturing services, and other manufacturing services) by end user (academic & research institutes, pharmaceutical & biotechnological companies, and hospitals & clinical laboratories). The report's scope encompasses detailed information regarding major influencing factors such as drivers, trends, challenges, and opportunities shaping the growth of the exosome research market. A comprehensive analysis of key industry players has been conducted to offer insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments, including new product launches, mergers, and acquisitions, in the exosome research market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall exosome research market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing investment in pharmaceutical and life sciences research, rising cancer prevalence, increasing interest in exosome-based procedures), restraints (Technical complexity of exosome isolation and technological limitations, regulatory uncertainty in exosome research), opportunities (Rising investments in emerging countries for exosome research, growing interest in exosome-based therapeutics, increasing demand for personalized medicine), and challenges (Lack of gold standard protocols for development & production of exosomes, limited understanding of cargo loading) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products in the exosome research market
• Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the exosome research market
• Competitive Assessment: Thermo Fisher Scientific, Inc. (US), Bio-Techne (US), System Biosciences, LLC (US), QIAGEN (Germany), Lonza (Switzerland), NX Pharmagen (US), NanoSomiX (US), Miltenyi Biotech (Germany), Norgen Biotek Corp. (Canada), AMSBio (UK), Aethlon Medical, Inc. (US), Anjarium Biosciences AG (UK), Ciloa (France), InnovaPrep LLC (US), Creative Medical Technologies Holdings, Inc. (US), ILIAS Biologics, Inc. (South Korea), Unchained Labs (US), Rion, Inc. (US), Cell Guidance System, LLC (UK), INOVIQ (Australia), Danaher Corporation (US), Exopharm (Australia), Everzom (France), RoosterBio, Inc. (US), and Creative Biolabs (US).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKETS COVERED
  • 1.3.1 MARKET SCOPE
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES
  • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 BREAKDOWN OF PRIMARIES: EXOSOME RESEARCH MARKET
• 2.2 MARKET ESTIMATION METHODOLOGY
  • FIGURE 3 EXOSOME RESEARCH MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022
  • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
  • FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
• 2.3 MARKET GROWTH RATE PROJECTIONS
  • FIGURE 6 EXOSOME RESEARCH MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
  • FIGURE 7 EXOSOME RESEARCH MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
  • 2.3.1 DATA TRIANGULATION
  • FIGURE 8 DATA TRIANGULATION METHODOLOGY
• 2.4 LIMITATIONS
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RISK ANALYSIS
• 2.7 RECESSION IMPACT
  • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2028 (% GROWTH)
  • TABLE 2 US: HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
  • TABLE 3 US: HEALTH EXPENDITURE, 2023-2030 (USD MILLION)

3 EXECUTIVE SUMMARY

• FIGURE 9 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
• FIGURE 10 EXOSOME RESEARCH MARKET, BY INDICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 11 EXOSOME RESEARCH MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 12 EXOSOME RESEARCH MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
• FIGURE 13 EXOSOME RESEARCH MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS

• 4.1 EXOSOME RESEARCH MARKET OVERVIEW
  • FIGURE 14 RISING INVESTMENTS IN PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH
• 4.2 EXOSOME RESEARCH MARKET: BY MANUFACTURING SERVICE
  • FIGURE 15 STEM CELL-DERIVED EXOSOME MANUFACTURING SERVICES TO HOLD LARGEST MARKET SHARE TILL 2028
• 4.3 ASIA PACIFIC: EXOSOME RESEARCH MARKET SHARE, BY APPLICATION & COUNTRY (2022)
  • FIGURE 16 BIOMARKERS ACCOUNTED FOR LARGEST SHARE OF APPLICATION SEGMENT IN 2022
• 4.4 EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023 VS. 2028 (USD MILLION)
  • FIGURE 17 LUNG CANCER SEGMENT CONTINUES TO DOMINATE MARKET IN 2028
• 4.5 EXOSOME RESEARCH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 18 NORTH AMERICA AND EUROPE MARKETS TO SHOW HIGHER GROWTH
• 4.6 EXOSOME RESEARCH MARKET SHARE, BY END USER, 2022
  • FIGURE 19 ACADEMIC & RESEARCH INSTITUTES TO DOMINATE MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 20 EXOSOME RESEARCH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 4 EXOSOME RESEARCH MARKET: IMPACT ANALYSIS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing investment in pharmaceutical and life sciences research
    • 5.2.1.2 Rising cancer prevalence
  • TABLE 5 GLOBAL CANCER INCIDENCE, 2022 VS. 2025
    • 5.2.1.3 Increasing interest in exosome-based procedures
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Technical complexity of exosome isolation and technological limitations
    • 5.2.2.2 Regulatory uncertainty in exosome research
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rising investments in emerging countries for exosome research
    • 5.2.3.2 Growing interest in exosome-based therapeutics
    • 5.2.3.3 Increasing demand for personalized medicine
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Lack of gold standard protocols for exosome development and production
    • 5.2.4.2 Limited understanding of cargo loading
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 21 REVENUE SHIFT AND NEW POCKETS FOR EXOSOME PROVIDERS
• 5.4 PRICING ANALYSIS
  • TABLE 6 AVERAGE SELLING PRICES OF KEY PLAYERS, BY PRODUCT
  • TABLE 7 REGIONAL VARIATIONS IN PRODUCT COSTS
• 5.5 VALUE CHAIN ANALYSIS
  • FIGURE 22 VALUE CHAIN ANALYSIS OF EXOSOME RESEARCH: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE
• 5.6 SUPPLY CHAIN ANALYSIS
  • FIGURE 23 EXOSOME RESEARCH MARKET: SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM/MARKET MAP
  • FIGURE 24 EXOSOME RESEARCH MARKET ECOSYSTEM
  • TABLE 8 EXOSOME RESEARCH MARKET: ROLE IN ECOSYSTEM
• 5.8 TECHNOLOGY ANALYSIS
  • TABLE 9 EXOSOME RESEARCH MARKET: TECHNOLOGY ANALYSIS-EXOSOME ISOLATION
  • TABLE 10 EXOSOME RESEARCH MARKET: TECHNOLOGY ANALYSIS-EXOSOME CHARACTERIZATION
  • TABLE 11 EXOSOME RESEARCH MARKET: TECHNOLOGY ANALYSIS-EXOSOME ANALYSIS
• 5.9 PATENT ANALYSIS
  • FIGURE 25 PATENT APPLICATIONS FOR EXOSOME RESEARCH MARKET, JANUARY 2013-OCTOBER 2023
  • TABLE 12 INDICATIVE LIST OF PATENTS IN EXOSOME RESEARCH MARKET
• 5.10 KEY CONFERENCES AND EVENTS, 2024-2025
  • TABLE 13 EXOSOME RESEARCH MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
• 5.11 REGULATORY ANALYSIS
  • 5.11.1 NORTH AMERICA
    • 5.11.1.1 US
    • 5.11.1.2 Canada
  • 5.11.2 EUROPE
    • 5.11.2.1 Germany
    • 5.11.2.2 France
    • 5.11.2.3 UK
  • 5.11.3 ASIA PACIFIC
    • 5.11.3.1 China
    • 5.11.3.2 Japan
    • 5.11.3.3 India
  • 5.11.4 REST OF THE WORLD
    • 5.11.4.1 Brazil
    • 5.11.4.2 Argentina
    • 5.11.4.3 Saudi Arabia
  • 5.11.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.12 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 18 EXOSOME RESEARCH MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.12.1 THREAT OF NEW ENTRANTS
  • 5.12.2 THREAT OF SUBSTITUTES
  • 5.12.3 BARGAINING POWER OF SUPPLIERS
  • 5.12.4 BARGAINING POWER OF BUYERS
  • 5.12.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EXOSOME PRODUCTS & SERVICES
  • 5.13.2 BUYING CRITERIA FOR EXOSOME PRODUCTS & SERVICES
  • FIGURE 27 KEY BUYING CRITERIA FOR END USERS

6 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE

• 6.1 INTRODUCTION
  • TABLE 19 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
• 6.2 KITS & REAGENTS
  • TABLE 20 EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 21 NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 22 EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 23 ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 24 EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 6.2.1 ANTIBODIES
    • 6.2.1.1 High demand for exosome-based markers for disease detection to propel growth
  • TABLE 25 EXOSOME RESEARCH ANTIBODIES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 26 NORTH AMERICA: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 27 EUROPE: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.2 ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS
    • 6.2.2.1 Availability of rapid and easy-to-use kits & reagents to ensure sustained demand
  • TABLE 29 EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 30 NORTH AMERICA: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 31 EUROPE: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 32 ASIA PACIFIC: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.2.3 OTHER KITS & REAGENTS
  • TABLE 33 OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 34 NORTH AMERICA: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 35 EUROPE: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.3 INSTRUMENTS
  • 6.3.1 DEMAND FOR SCALABLE EXOSOME DEVELOPMENT VIA HIGH-THROUGHPUT SYSTEMS TO DRIVE GROWTH
  • TABLE 37 EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 38 NORTH AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 39 EUROPE: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
• 6.4 SERVICES
  • 6.4.1 LACK OF IN-HOUSE RESOURCES TO SUPPORT GROWTH OF SERVICES SECTOR
  • TABLE 41 EXOSOME RESEARCH SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 42 NORTH AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 43 EUROPE: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 44 ASIA PACIFIC: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 EXOSOME RESEARCH MARKET, BY INDICATION

• 7.1 INTRODUCTION
  • TABLE 45 EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
• 7.2 CANCER
  • TABLE 46 EXOSOME RESEARCH MARKET FOR CANCER, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 47 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 48 EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 50 EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • 7.2.1 LUNG CANCER
    • 7.2.1.1 Increasing prevalence and advancements in instruments and assays for liquid biopsy to drive market
  • TABLE 51 EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 52 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 53 EUROPE: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.2.2 BREAST CANCER
    • 7.2.2.1 High prevalence and increasing awareness to drive market
  • TABLE 55 EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 56 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 57 EUROPE: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.2.3 PROSTATE CANCER
    • 7.2.3.1 Effectiveness of liquid biopsy in detecting prostate cancer before surgery to support market growth
  • TABLE 59 EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 60 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 61 EUROPE: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.2.4 COLORECTAL CANCER
    • 7.2.4.1 Increasing exosome-based research and projects to propel market
  • TABLE 63 EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 64 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 65 EUROPE: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.2.5 OTHER CANCERS
  • TABLE 67 EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 68 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 69 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.3 NEURODEGENERATIVE DISEASES
  • 7.3.1 POTENTIAL APPLICATIONS OF SALIVARY EXOSOMAL CARGO CONTENT IN TREATMENT TO DRIVE MARKET
  • TABLE 71 EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 72 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 73 EUROPE: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.4 CARDIOVASCULAR DISEASES
  • 7.4.1 EXPANDING RESEARCH ON CVD APPLICATIONS TO PROPEL SEGMENT GROWTH
  • TABLE 75 EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 76 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 77 EUROPE: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.5 INFECTIOUS DISEASES
  • 7.5.1 POTENTIAL FOR DEEPER UNDERSTANDING OF INFECTIOUS DISEASE THERAPEUTICS TO DRIVE MARKET
  • TABLE 79 EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 80 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 81 EUROPE: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
• 7.6 OTHER INDICATIONS
  • TABLE 83 EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 84 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 85 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 86 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

8 EXOSOME RESEARCH MARKET, BY APPLICATION

• 8.1 INTRODUCTION
  • TABLE 87 EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 8.2 BIOMARKERS
  • 8.2.1 BIOMARKERS TO HOLD LARGEST SHARE OF APPLICATIONS MARKET
  • TABLE 88 EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 89 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 90 EUROPE: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 91 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.3 VACCINE DEVELOPMENT
  • 8.3.1 GROWING INTEREST IN EXOSOMES IN INFECTIOUS DISEASE THERAPEUTICS TO DRIVE MARKET
  • TABLE 92 EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 93 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 94 EUROPE: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.4 TISSUE REGENERATION
  • 8.4.1 MINIMAL SIDE EFFECTS AND HIGH EFFICACY OF EXOSOMES TO SUPPORT ADOPTION
  • TABLE 96 EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 97 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 98 EUROPE: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2021-2028 (USD MILLION)
• 8.5 OTHER APPLICATIONS
  • TABLE 100 EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 101 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 102 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 EXOSOME RESEARCH MARKET, BY END USER

• 9.1 INTRODUCTION
  • TABLE 104 EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.2 ACADEMIC & RESEARCH INSTITUTES
  • 9.2.1 ACADEMIC & RESEARCH INSTITUTES TO HOLD LARGEST SHARE OF END-USER MARKET
  • TABLE 105 EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 106 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 107 EUROPE: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 108 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.3.1 SIGNIFICANT DEVELOPMENTS IN NANOMEDICINE TO DRIVE MARKET
  • TABLE 109 EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 110 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 111 EUROPE: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 112 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
• 9.4 HOSPITALS & CLINICAL TESTING LABORATORIES
  • 9.4.1 RISING ADOPTION OF EXOSOME-BASED ONCOLOGY RESEARCH SOLUTIONS TO DRIVE MARKET
  • TABLE 113 EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 114 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 115 EUROPE: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)

10 EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE

• 10.1 INTRODUCTION
  • TABLE 117 EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE, 2021-2028 (USD MILLION)
• 10.2 STEM CELL-DERIVED EXOSOME MANUFACTURING
  • 10.2.1 RISING DEMAND FOR MSC EXOSOMES IN THERAPEUTICS TO DRIVE MARKET
• 10.3 DENDRITIC CELL-DERIVED EXOSOME MANUFACTURING
  • 10.3.1 SIGNIFICANT DEVELOPMENTS IN DC-EXOSOME IMMUNOTHERAPY TO PROPEL GROWTH
• 10.4 OTHER EXOSOME MANUFACTURING SERVICES

11 EXOSOME RESEARCH MARKET, BY REGION

• 11.1 INTRODUCTION
  • TABLE 118 EXOSOME RESEARCH MARKET, KEYWORD ANALYSIS (2001-2022)
  • TABLE 119 EXOSOME RESEARCH MARKET, BY REGION, 2021-2028 (USD MILLION)
• 11.2 NORTH AMERICA
  • FIGURE 28 NORTH AMERICA: EXOSOME RESEARCH MARKET SNAPSHOT
  • TABLE 120 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 121 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 122 NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 123 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 124 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 125 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 126 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2.1 US
    • 11.2.1.1 HIGH BURDEN OF CANCER AND FAVORABLE PUBLIC & PRIVATE FUNDING FOR RESEARCH TO DRIVE MARKET
  • TABLE 127 US: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 128 US: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 129 US: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 130 US: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 131 US: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 132 US: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2.2 CANADA
    • 11.2.2.1 INCREASING FUNDING FOR GENOME-BASED MEDICAL TREATMENTS TO SUPPORT MARKET GROWTH
  • TABLE 133 CANADA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 134 CANADA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 135 CANADA: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 136 CANADA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 137 CANADA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 138 CANADA: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2.3 NORTH AMERICA: RECESSION IMPACT
• 11.3 EUROPE
  • FIGURE 29 EUROPE: EXOSOME RESEARCH MARKET SNAPSHOT
  • TABLE 139 EUROPE: EXOSOME RESEARCH MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 140 EUROPE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 141 EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 142 EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 143 EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 144 EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 145 EUROPE: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.1 GERMANY
    • 11.3.1.1 Germany to dominate European market
  • TABLE 146 GERMANY: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 147 GERMANY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 148 GERMANY: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 149 GERMANY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 150 GERMANY: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 151 GERMANY: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.2 UK
    • 11.3.2.1 Growing life sciences industry to drive market
  • TABLE 152 UK: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 153 UK: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 154 UK: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 155 UK: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 156 UK: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 157 UK: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.3 FRANCE
    • 11.3.3.1 Strong collaborative network between biotechnology entities and research institutes to support growth
  • TABLE 158 FRANCE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 159 FRANCE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 160 FRANCE: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 161 FRANCE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 162 FRANCE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 163 FRANCE: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.4 REST OF EUROPE
  • TABLE 164 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 165 REST OF EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 166 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 167 REST OF EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 168 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 169 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.5 EUROPE: RECESSION IMPACT
• 11.4 ASIA PACIFIC
  • TABLE 170 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 172 ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 174 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 176 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.1 CHINA
    • 11.4.1.1 China to hold largest share in APAC market
  • TABLE 177 CHINA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 178 CHINA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 179 CHINA: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 180 CHINA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 181 CHINA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 182 CHINA: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.2 JAPAN
    • 11.4.2.1 High cancer prevalence and increasing healthcare expenditure to drive market
  • TABLE 183 TOTAL NUMBER OF CLINICAL TRIALS IN JAPAN, BY THERAPEUTIC AREA, 2020 VS. 2022
  • TABLE 184 JAPAN: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 185 JAPAN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 186 JAPAN: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 187 JAPAN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 188 JAPAN: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 189 JAPAN: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.3 REST OF ASIA PACIFIC
  • TABLE 190 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 191 REST OF ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 192 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 193 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 194 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 195 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.4 ASIA PACIFIC: RECESSION IMPACT
• 11.5 REST OF THE WORLD
  • TABLE 196 REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • TABLE 197 REST OF THE WORLD: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 198 REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY INDICATION, 2021-2028 (USD MILLION)
  • TABLE 199 REST OF THE WORLD: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 200 REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 201 REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.5.1 REST OF THE WORLD: RECESSION IMPACT

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • FIGURE 30 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2020- 2023
• 12.3 REVENUE ANALYSIS
  • FIGURE 31 REVENUE ANALYSIS OF TOP FIVE MARKET PLAYERS (2018-2022)
• 12.4 MARKET SHARE ANALYSIS
  • TABLE 202 EXOSOME RESEARCH MARKET: DEGREE OF COMPETITION
• 12.5 COMPANY EVALUATION MATRIX
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE
  • 12.5.4 EMERGING COMPANIES
  • FIGURE 33 EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX, 2022
  • 12.5.5 COMPANY FOOTPRINT
  • TABLE 203 COMPANY FOOTPRINT (25 COMPANIES)
  • TABLE 204 PRODUCT & SERVICE FOOTPRINT (25 COMPANIES)
  • TABLE 205 GEOGRAPHIC FOOTPRINT (25 COMPANIES)
• 12.6 START-UP/SME EVALUATION MATRIX
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 STARTING BLOCKS
  • 12.6.3 RESPONSIVE COMPANIES
  • 12.6.4 DYNAMIC COMPANIES
  • FIGURE 34 EXOSOME RESEARCH MARKET: START-UP/SME EVALUATION MATRIX, 2022
  • 12.6.5 COMPETITIVE BENCHMARKING
  • TABLE 206 EXOSOME RESEARCH MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
  • TABLE 207 EXOSOME RESEARCH MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES]
• 12.7 COMPETITIVE SCENARIO

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
• (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
• 13.1.1 THERMO FISHER SCIENTIFIC INC.
• TABLE 208 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
• FIGURE 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
• 13.1.2 QIAGEN
• TABLE 209 QIAGEN: COMPANY OVERVIEW
• FIGURE 36 QIAGEN: COMPANY SNAPSHOT (2022)
• 13.1.3 LONZA
• TABLE 210 LONZA: COMPANY OVERVIEW
• FIGURE 37 LONZA: COMPANY SNAPSHOT (2022)
• 13.1.4 SYSTEM BIOSCIENCES, LLC
• TABLE 211 SYSTEM BIOSCIENCES, LLC: COMPANY OVERVIEW
• 13.1.5 BIO-TECHNE
• TABLE 212 BIO-TECHNE: COMPANY OVERVIEW
• FIGURE 38 BIO-TECHNE: COMPANY SNAPSHOT (2022)
• 13.1.6 DANAHER CORPORATION
• TABLE 213 DANAHER CORPORATION: COMPANY OVERVIEW
• FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
• 13.1.7 AMSBIO
• TABLE 214 AMSBIO: COMPANY OVERVIEW
• 13.1.8 ROOSTERBIO, INC.
• TABLE 215 ROOSTERBIO, INC.: COMPANY OVERVIEW
• 13.1.9 MILTENYI BIOTEC
• TABLE 216 MILTENYI BIOTEC: COMPANY OVERVIEW
• 13.1.10 NORGEN BIOTEK CORP.
• TABLE 217 NORGEN BIOTEK CORP.: COMPANY OVERVIEW
• 13.2 OTHER PLAYERS
  • 13.2.1 AETHLON MEDICAL, INC.
  • 13.2.2 ANJARIUM BIOSCIENCES AG
  • 13.2.3 CILOA
  • 13.2.4 INNOVAPREP, LLC
  • 13.2.5 CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC,
  • 13.2.6 ILIAS BIOLOGICS INC.
  • 13.2.7 UNCHAINED LABS
  • 13.2.8 RION INC.
  • 13.2.9 CELL GUIDANCE SYSTEMS LLC
  • 13.2.10 INOVIQ
  • 13.2.11 NX PHARMAGEN
  • 13.2.12 EXOPHARM
  • 13.2.13 EVERZOM
  • 13.2.14 NANOSOMIX
  • 13.2.15 CREATIVE BIOLABS
• *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

관련자료